+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vortioxetine"

From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Vortioxetine is a medication used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). It is a serotonin modulator and stimulator (SMS) that works by increasing the levels of serotonin in the brain. Vortioxetine is a relatively new drug, having been approved by the U.S. Food and Drug Administration (FDA) in 2013. It is available in both immediate-release and extended-release formulations. Vortioxetine is one of several drugs used to treat mental disorders, including antidepressants, antipsychotics, and mood stabilizers. It is generally well-tolerated and has fewer side effects than other drugs in its class. It is also used off-label to treat other conditions, such as obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD). The market for vortioxetine is growing, as it is becoming increasingly accepted as an effective treatment for mental disorders. It is also becoming more widely available, with many generic versions now available. Some companies in the vortioxetine market include Lundbeck, Takeda Pharmaceuticals, and Mylan. Show Less Read more